MealEnders Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • (Cancelled)
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 2

MealEnders General Information

Description

Producer of a weight management product created to help people beat overeating, master portion control, and curb snacking. The company's product specializes in providing appetite control, weight loss, and dietary supplements and preparations in various forms namely, mints, pills, chewing gum, dissolving strips, shots, drinks, drops, sprays, toothpaste, toothpicks, dental floss, and lozenges, enabling customers to lose weight, eat healthily and stay well.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Food Products
Primary Office
  • 38 Keyes Avenue
  • Suite 116
  • San Francisco, CA 94129
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MealEnders Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 25-Mar-2019 $1.5M Cancelled Generating Revenue
3. Angel (individual) 03-Mar-2017 Cancelled Generating Revenue
2. Angel (individual) 01-Jan-2014 $1.2M $1.4M Completed Generating Revenue
1. Capitalization 01-Jan-2013 $200K $200K Completed Startup
To view MealEnders’s complete valuation and funding history, request access »

MealEnders Executive Team (3)

Name Title Board Seat Contact Info
Mark Bernstein Founder & Chief Executive Officer
Dana Doron Chief Marketing Officer
Tami Lyon Chief Nutrition Officer
To view MealEnders’s complete executive team members history, request access »

MealEnders Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Howard Zack Angel (individual) Minority 000 0000 000000 0
John Silberstein Angel (individual) Minority 000 0000 000000 0
To view MealEnders’s complete investors history, request access »